Who owns Y Mabs Therapeutics Inc?
- CUSIP Number: 984241109
Tip: Access positions for across all investors
Analyze quarterly positions in Y Mabs Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Y Mabs Therapeutics stock
Who bought or sold Y Mabs Therapeutics Inc this quarter?
There are no current stakeholders of Y Mabs Therapeutics.
This is normal when the security:
- Has been acquired or taken private
- Has merged with another entity
- Has changed its name and has a new CUSIP (and/or symbol)
- Has been delisted and the ticker has changed
Please use Search to find the security you were looking for.
Who sold out of Y Mabs Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| D. E. Shaw & Co | Jun 2025 | 517k | $2.3M |
| AQR Capital Management | Jun 2025 | 252k | $1.1M |
| Citadel Advisors | Jun 2025 | 232k | $1.0M |
| Millennium Management | Jun 2025 | 140k | $631k |
| Two Sigma Investments | Jun 2025 | 125k | $565k |
| Two Sigma Advisers | Jun 2025 | 116k | $522k |
| Cubist Systematic Strategies | Jun 2025 | 70k | $315k |
| Alliancebernstein | Jun 2025 | 59k | $268k |
| Bridgeway Capital Management | Jun 2025 | 56k | $251k |
| FMR | Jun 2025 | 31k | $139k |
| Skopos Labs | Sep 2025 | 16k | $76k |